BRISBANE: ImpediMed Limited announced a second contract valued at over $2.0 million for its SOZO Digital Health Platform to be used in a clinical trial being conducted for AstraZeneca, a global pharmaceutical company. The Phase II trial will use the SOZO devices to track patient fluid volume in an upcoming pharmaceutical study focused on chronic…